These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37187449)

  • 1. Cannabidiol alleviates right ventricular fibrosis by inhibiting the transforming growth factor β pathway in monocrotaline-induced pulmonary hypertension in rats.
    Krzyżewska A; Baranowska-Kuczko M; Kasacka I; Kozłowska H
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166753. PubMed ID: 37187449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol inhibits lung proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Krzyżewska A; Baranowska-Kuczko M; Kasacka I; Kozłowska H
    Biomed Pharmacother; 2023 Mar; 159():114234. PubMed ID: 36634588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension.
    Krzyżewska A; Baranowska-Kuczko M; Jastrząb A; Kasacka I; Kozłowska H
    Molecules; 2022 May; 27(10):. PubMed ID: 35630804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol may prevent the development of congestive hepatopathy secondary to right ventricular hypertrophy associated with pulmonary hypertension in rats.
    Krzyżewska A; Baranowska-Kuczko M; Galicka A; Kasacka I; Mińczuk K; Kozłowska H
    Pharmacol Rep; 2024 Apr; 76(2):424-434. PubMed ID: 38519732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.
    Sadowska O; Baranowska-Kuczko M; Gromotowicz-Popławska A; Biernacki M; Kicman A; Malinowska B; Kasacka I; Krzyżewska A; Kozłowska H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
    Comarița IK; Tanko G; Anghelache IL; Georgescu A
    J Transl Med; 2024 Feb; 22(1):137. PubMed ID: 38317144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 contributes to vascular fibrosis in monocrotaline-induced pulmonary arterial hypertension rat model.
    Wang X; Wang Y; Zhang J; Guan X; Chen M; Li Y; Zhang L
    J Biochem Mol Toxicol; 2017 May; 31(5):. PubMed ID: 27870162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic investigation of wogonin in delaying the progression of endothelial mesenchymal transition by targeting the TGF-β1 pathway in pulmonary hypertension.
    Wang X; Cui L; Wang Y; Zeng Z; Wang H; Tian L; Guo J; Chen Y
    Eur J Pharmacol; 2024 Sep; 978():176786. PubMed ID: 38942264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfur Dioxide Protects Against Collagen Accumulation in Pulmonary Artery in Association With Downregulation of the Transforming Growth Factor β1/Smad Pathway in Pulmonary Hypertensive Rats.
    Yu W; Liu D; Liang C; Ochs T; Chen S; Chen S; Du S; Tang C; Huang Y; Du J; Jin H
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
    Okada M; Harada T; Kikuzuki R; Yamawaki H; Hara Y
    J Pharmacol Sci; 2009 Oct; 111(2):193-200. PubMed ID: 19809219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension via the Inhibition of TGF-
    Xiang Y; Cai C; Wu Y; Yang L; Ye S; Zhao H; Zeng C
    Evid Based Complement Alternat Med; 2020; 2020():9238428. PubMed ID: 33335559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
    Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
    Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
    Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
    Lee FY; Lu HI; Zhen YY; Leu S; Chen YL; Tsai TH; Chung SY; Chua S; Sheu JJ; Hsu SY; Chang HW; Sun CK; Yip HK
    Eur J Pharm Sci; 2013 Nov; 50(3-4):372-84. PubMed ID: 23954457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.
    Zaiman AL; Podowski M; Medicherla S; Gordy K; Xu F; Zhen L; Shimoda LA; Neptune E; Higgins L; Murphy A; Chakravarty S; Protter A; Sehgal PB; Champion HC; Tuder RM
    Am J Respir Crit Care Med; 2008 Apr; 177(8):896-905. PubMed ID: 18202349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of rutaecarpine on right ventriclar remodeling in rats with monocrotaline-induced pulmonary hypertension].
    Li XW; Wang XM; Li S; Yang JR
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):405-10. PubMed ID: 25571629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.